Radioactive contamination
Some organs concentrate certain elements and hence radionuclide variants of those elements. This action may lead to much lower removal rates. For instance, the thyroid gland takes up a large percentage of any iodine that enters the body. Large quantities of inhaled or ingested radioactive iodine may impair or destroy the thyroid, while other tissues are affected to a lesser extent. Radioactive iodine-131 is a common fission product; it was a major component of the radioactivity released from the Chernobyl disaster, leading to nine fatal cases of pediatric thyroid cancer and hypothyroidism. On the other hand, radioactive iodine is used in the diagnosis and treatment of many diseases of the thyroid precisely because of the thyroid's selective uptake of iodine.
Hyperthyroidism
In iodine-131 (radioiodine) radioisotope therapy, which was first pioneered by Dr. Saul Hertz, radioactive iodine-131 is given orally (either by pill or liquid) on a one-time basis, to severely restrict, or altogether destroy the function of a hyperactive thyroid gland. This isotope of radioactive iodine used for ablative treatment is more potent than diagnostic radioiodine (usually iodine-123 or a very low amount of iodine-131), which has a biological half-life from 8–13 hours. Iodine-131, which also emits beta particles that are far more damaging to tissues at short range, has a half-life of approximately 8 days. Patients not responding sufficiently to the first dose are sometimes given an additional radioiodine treatment, at a larger dose. Iodine-131 in this treatment is picked up by the active cells in the thyroid and destroys them, rendering the thyroid gland mostly or completely inactive.